EIF2B3 (eIF2Bγ) is a subunit of the guanine nucleotide exchange factor eIF2B that supports cap-independent, HCV IRES-mediated translation and, when disrupted, perturbs glial development and cellular stress tolerance (PMID:10900014, PMID:33517449). In hepatocyte models, EIF2B3 acts as a cofactor required for HCV IRES-driven core protein synthesis and for chronic HCV replication, selectively affecting IRES translation without impairing cap-dependent translation or cell growth (PMID:10900014, PMID:23207339). Disease-associated EIF2B3 mutation impairs oligodendrocyte survival under ER stress by depressing autophagy flux, with reduced Atg3 and Atg7 expression, and pharmacological autophagy induction rescues mutant cell viability, placing EIF2B3 upstream of autophagy-mediated ER stress tolerance (PMID:26625702). In vivo, CRISPR ablation of eif2b3 in zebrafish disrupts myelin development and glial differentiation, induces integrated stress response genes, and drives ectopic VEGF-dependent angiogenesis reversible by VEGF receptor inhibition, a model that validated pathogenicity of human EIF2B3 disease variants (PMID:33517449). Beyond these findings, the biochemical mechanism of EIF2B3 within the eIF2B nucleotide exchange complex has not been directly characterized in the available corpus.